AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
HLS Therapeutics Inc.
$3.25
-$0.18 (-5.25%)
Previous Close
$3.24
Day Range
$3.24$3.25
Year Range
$2.64$4.02
Market Cap
100.54M
AVG Volume
591
Trailing/Forward PE
-12.23/-
PEG ratio
0.26
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
Other OTC
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: HLTRF
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.
Video analysis: HLTRF
All videosNo video analysis for this stock yet. Request one from our team.
News: HLTRF
Similar companies
-
Minerva Neurosciences, Inc.
NERV
·
NASDAQ
Compare
-
Cumberland Pharmaceuticals Inc.
CPIX
·
NASDAQ
Compare
-
Aquestive Therapeutics, Inc.
AQST
·
NASDAQ
Compare
-
Eton Pharmaceuticals, Inc.
ETON
·
NASDAQ
Compare
-
Bausch Health Companies Inc.
BHC
·
New York Stock Exchange
Compare
-
Amneal Pharmaceuticals, Inc.
AMRX
·
NASDAQ
Compare